Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1995
10/31/1995US5463048 Rapamycin amidino carbamates
10/31/1995US5462953 Benzoxazolyl derivatives useful as 5-lipoxygenase inhibitors
10/31/1995US5462952 Fenamate 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as antiinflammatory agents
10/31/1995US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462932 Aqueous, buffered alendronate solution containing a complexing agent to prevent precipitation; bone loss prevention
10/31/1995US5462925 Transforming growth factor β2,3
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028386A1 Substituted pyridine leukotriene b4 antagonists
10/26/1995WO1995028163A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995WO1995022537A3 4-amino derivatives of 5-substituted mycophenolic acid
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2186738A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995CA2186252A1 Substituted pyridine leukotriene b4 antagonists
10/26/1995CA2183991A1 Tachykinin antagonists
10/25/1995EP0678297A1 Iontophoretic transdermal delivery of deoxyspergualin compounds
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678097A1 Novel colon- or ileum-specific steroid derivatives
10/25/1995CN1110600A Antalgic paster and its preparation method
10/24/1995US5461070 Anti-flammatory method using indole alkaloids
10/24/1995CA1337399C Ibuprofen taste-masking process
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027713A1 Process for the resolution of etodolac using glucamine derivatives
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027502A1 Method of treating auto-immune diseases using type one interferons
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187550A1 Method of treating auto-immune diseases using type one interferons
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677051A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
10/18/1995EP0676962A1 Enhanced pharmaceutical compositions for skin penetration
10/18/1995EP0356435B1 Anti-inflammatory compounds and compositions
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1030075C Process for preparing 3-cycloalkyl-propanamides, their tautomer forms and their salts
10/17/1995US5459270 Tachykinin antagonist for central nervous systum disorders and cardiovascular disorders
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459150 Treatment of allergies and inflammatory diseases
10/17/1995US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/17/1995CA2060789C Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
10/12/1995WO1995027202A1 Screening method using the rzr receptor family
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026958A1 Pyrimidinyl derivatives as interleukin inhibitors
10/12/1995WO1995026738A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186758A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/11/1995EP0676472A1 Human manganese superoxide dismutase (hMn-SOD)
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675901A1 Difluoro-pentapeptide derivative anti-inflammatory agents
10/11/1995EP0675892A1 Novel phosphorus-containing spin-trap compositions
10/11/1995EP0675886A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
10/11/1995EP0675881A1 Use of benzotriazines as pla 2? inhibitors, and new benzotriazines.
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675721A1 Pharmaceutical compositions comprising contignasterol compounds
10/11/1995EP0675718A1 Substituted pyridyl compounds useful as leukotriene antagonists
10/11/1995CN1110057A Tricyclic defem sulphones as elastase inhibitors
10/11/1995CN1109884A Methods of inhibiting myeloperoxidase activity
10/11/1995CN1109745A Ibuprofen-containing solid composition
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457124 Antiinflammatory agent
10/10/1995US5457090 A serine proteolytic enzyme inhibitor
10/10/1995US5456918 Ranitidine pharmaceutical compositions
10/10/1995US5456909 Used in therapy and diagnosis of inflammatory and immune disorders
10/10/1995CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions
10/10/1995CA1337272C Drug adsorbates
10/05/1995WO1995026403A1 Antibodies against e-selectin
10/05/1995WO1995026352A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026350A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026346A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
10/05/1995WO1995026342A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026339A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
10/05/1995CA2186455A1 Antibodies against e-selectin
10/05/1995CA2184754A1 5h-indeno[1,2-b]pyrazine-2,3-dione derivatives, preparation thereof and drugs containing same
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0675103A2 Derivatives of essential fatty acids and nonsteroidal antiinflammatory drugs
10/04/1995EP0674642A1 Pyrazolopyrimidines as crf antagonists
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
1 ... 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 ... 1272